MAPT and Alzheimer disease: Even if tau protein is considered as a major biomarker of AD, the protein is also increased when measured by ELISA in other tauopathies like Creutzfeldt–Jakob Disease or Fronto Temporal Dementia (Green et al., 1999; Wang et al., 2010).